ID   BL-10
AC   CVCL_C131
SY   BL10; BL 10; IARC/BL10; IARC/BL 10; IARC-BL10; IARC BL10; IARC BL 10
DR   Cosmic; 931116
DR   Wikidata; Q54797092
RX   PubMed=3934070;
RX   PubMed=6825067;
RX   PubMed=9473234;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C143 ! BL-31
OI   CVCL_VQ18 ! IARC-113
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 12
//
RX   PubMed=3934070;
RA   Lenoir G.M., Vuillaume M., Bonnardel C.;
RT   "The use of lymphomatous and lymphoblastoid cell lines in the study of
RT   Burkitt's lymphoma.";
RL   IARC Sci. Publ. 60:309-318(1985).
//
RX   PubMed=6825067; DOI=10.1016/0165-4608(83)90138-3;
RA   Bernheim A., Berger R., Lenoir G.M.;
RT   "Cytogenetic studies on Burkitt's lymphoma cell lines.";
RL   Cancer Genet. Cytogenet. 8:223-229(1983).
//
RX   PubMed=9473234; DOI=10.1182/blood.V91.5.1680;
RA   Klangby U., Okan I., Magnusson K.P., Wendland M., Lind P., Wiman K.G.;
RT   "p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a
RT   mRNA and protein expression in Burkitt's lymphoma.";
RL   Blood 91:1680-1687(1998).
//